WordNet

of or relating to cytolysis, the dissolution or destruction of a cell

English Journal

Human AdV-specific T cells: persisting in vitro functionality despite lethal irradiation.

Geyeregger R1, Freimüller C1, Stemberger J1, Fischer G2, Witt V3, Fritsch G4.
Bone marrow transplantation.Bone Marrow Transplant.2014 Jul;49(7):934-41. doi: 10.1038/bmt.2014.86. Epub 2014 Apr 28.
Viral infections caused by human adenovirus (HAdV) or CMV remain life-threatening complications in immunocompromised patients undergoing allogeneic hematopoietic stem cell transplantation. Adoptive immunotherapy with virus-specific T cells showed impressive clinical results without or with only mi
PMID 24777182

Eosinophil extracellular DNA trap cell death mediates lytic release of free secretion-competent eosinophil granules in humans.

Ueki S1, Melo RC, Ghiran I, Spencer LA, Dvorak AM, Weller PF.
Blood.Blood.2013 Mar 14;121(11):2074-83. doi: 10.1182/blood-2012-05-432088. Epub 2013 Jan 9.
Eosinophils release their granule proteins extracellularly through exocytosis, piecemeal degranulation, or cytolytic degranulation. Findings in diverse human eosinophilic diseases of intact extracellular eosinophil granules, either free or clustered, indicate that eosinophil cytolysis occurs in vivo
PMID 23303825

Toward integrative cancer immunotherapy: targeting the tumor microenvironment.

Emens LA, Silverstein SC, Khleif S, Marincola FM, Galon J.
Journal of translational medicine.J Transl Med.2012 Apr 10;10:70. doi: 10.1186/1479-5876-10-70.
The development of cancer has historically been attributed to genomic alterations of normal host cells. Accordingly, the aim of most traditional cancer therapies has been to destroy the transformed cells themselves. There is now widespread appreciation that the progressive growth and metastatic spre
PMID 22490302

Japanese Journal

Bioactive interleukin-1α is cytolytically released from Candida albicans-infected oral epithelial cells

DONGARI-BAGTZOGLOU A
Med Mycol 42, 531-541, 2004
NAID 30014971377

The cytolytically inactive terminal complement complex activates endothelial cells to express adhesion molecules and tissue factor procoagulant activity

TEDESCO F.
J Exp Med 185, 1619-1627, 1997
NAID 30017415640

Immune complex vasculitisの血管傷害における補体membrane attack complexの関与

沈国雄,川名誠司,西山茂夫
北里医学 24(6), 573-580, 1994-12-31
この研究は2つの要素から構成されている。第1に,immune complex vasculitis患者皮膚罹患血管壁におけるmembrane attack complex of complement (MAC)の形成を螢光抗体直接法で観察し,さらに同患者の血清中のSC5b-9量をenzyme immunosorbent assayで測定した。その結果,Henoch-Schonlein purpur …
NAID 110004696752

Related Links

Anti-C5b-9 抗体 [aE11] (ab66768) | アブカム

Fluid phase binding of the multifunctional glycoprotein S protein (vitronectin) to C5b9 leads to the formation of a cytolytically inactive complex, SC5b9, which is unable to attach to cells. 細胞内局在 Secreted 参照データベース ...

Anti-C5b-9 抗体 (ab55811) | アブカム

Fluid phase binding of the multifunctional glycoprotein S protein (vitronectin) to C5b9 leads to the formation of a cytolytically inactive complex, SC5b9, which is unable to attach to cells. 細胞内局在 Secreted 参照データベース ...

Anti-Complement 5b-9 Rabbit pAb | 204903

C5b-9 is the cytolytically active glycoprotein complex, comprised of C5b, C6, C7, C8 and C9 complement proteins, formed as a result of complement activation via either the classical or alternative pathways. Host Rabbit Human ...